Biocon Biologics to Acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in Stock and Cash

Go back to Biocon Biologics to Acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in Stock and Cash
(NASDAQ: VTRS) Delayed: 15.63 +0.25 (1.63%)
Previous Close $15.38    52 Week High
Open $15.32    52 Week Low
Day High $15.66    P/E N/A 
Day Low $15.22    EPS
Volume 1,341,368